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Abstract: Haemostatic disorders are both complex and costly in relation to both their treatment and
subsequent management. As leading causes of mortality worldwide, there is an ever-increasing drive
to improve the diagnosis and prevention of haemostatic disorders. The field of microfluidic and Lab
on a Chip (LOC) technologies is rapidly advancing and the important role of miniaturised diagnostics
is becoming more evident in the healthcare system, with particular importance in near patient testing
(NPT) and point of care (POC) settings. Microfluidic technologies present innovative solutions to
diagnostic and clinical challenges which have the knock-on effect of improving health care and quality
of life. In this review, both advanced microfluidic devices (R&D) and commercially available devices
for the diagnosis and monitoring of haemostasis-related disorders and antithrombotic therapies,
respectively, are discussed. Innovative design specifications, fabrication techniques, and modes of
detection in addition to the materials used in developing micro-channels are reviewed in the context
of application to the field of haemostasis.
Keywords: coagulation; haemostasis; LOC; MEMS; microfluidics; POC

1. Introduction
Haemostasis is a complex wound healing process, activated by nearly eighty biochemical reactions
that arrest blood at the site of injury while maintaining normal blood flow elsewhere in a vascular
system [1]. A haemostatic imbalance can lead to either excessive bleeding or undesired clotting
conditions. It is expected that, by 2030, the treatment cost for blood coagulation related disorders will
rise to approximately USD 800 billion [2]. Complex vascular networks and blood flow parameters can
be modelled using microfluidics to aid the understanding of the pathophysiology of blood disorders [3].
Broadly, microfluidics refers to the handling and manipulation of, typically sub millilitre, volumes of
fluids. The particular physical laws governing fluids at this level have led to new areas of research with
many diverse applications [4]. Lab on a chip (LOC) technology, largely enabled through microfluidics,
is a multidisciplinary subject dedicated to the development of laboratory experiments carried out in
a miniaturised format. The miniaturised nature of these LOC devices typically results in the design
and manufacture of fluidic networks with sub millimetre characteristic dimensions [5]. Among the
major advantages of microfluidic and LOC technology in the field of biology and biochemistry is
its application to high-throughput screening (HTS). HTS is now a well-established technology used
primarily in drug discovery. With an increase in the number of compounds and molecular targets
available, major pharmaceutical and biotechnology companies are using HTS technologies such as
robotics, lab automation, optimised detectors, etc. to screen 10,000–100,000 compounds daily [6]. The
screening of compounds can be achieved with cost-effective miniaturisation technology, which not
only reduces the consumption of reagents but also efficiently manages parallel sample-processing in a
shorter period compared to alternative conventional methods [7].
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Thrombosis is the leading cause of morbidity and mortality, responsible for approximately one
in four deaths worldwide, based on the statistics derived from the Global Burden of Diseases study
from 1990–2010 [8,9]. Thrombus (clot) formation is the result of an interaction of platelets at the
site of injury and the meshwork around the platelets formed by fibrin (fibre-like protein) deposition.
Arterial thrombosis results in the formation of platelet-rich clots in the presence of a high shear rate,
whereas venous thrombosis is the result of fibrin-rich clots occurring at low shear rates. The dynamic
shear rate driving the blood flow in a complex vascular network of varied dimensions is a crucial
factor responsible for both venous and arterial thrombosis [10]. Micro-fabrication technology has
created new horizons for novel designs in microfluidic devices that can imitate diverse physiologically
relevant structures required for the investigation of multi-factorial causes of thrombosis [11]. With the
progressions in protein adhesion techniques in microfluidic devices, the biomimetic micro-channels
can be internally coated with appropriate biological substrates, such as von Willebrand factor (VWF),
collagen, Tissue Factor (TF) or fibrinogen. Furthermore, these micro-channels can be designed to attain
shear stresses ranging from low venous to high arterial, resembling in vivo conditions within the same
device for examining the role of platelet adhesion during thrombosis [12].
The global market share for antithrombotic drugs is 53.1% of all the drugs for cardiovascular
disease (CVD) [13]. Typically, antithrombotic drugs, which are broadly categorized as anticoagulants
and antiplatelets drugs, require continuous monitoring to reduce the risk of excessive bleeding or
clotting [14]. Aspirin is the first line of treatment as an antiplatelet drug while warfarin and heparin are
the commonly prescribed anticoagulants in cardiovascular therapy [15]. Conventional clot-based assays
include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin clotting time
(TCT), and activated clotting time (ACT). These assays are used for evaluating associated coagulopathic
conditions and monitoring antithrombotic therapy. In laboratory settings, a PT test is performed by
measuring the clotting time after adding a TF reagent and calcium to the plasma. The prolongation in
PT is converted to the international normalised ratio (INR) and facilitates monitoring of PT/INR [16].
Miniaturised point of care (POC) devices for home monitoring and self-testing are hugely popular due
to their rapid turnaround time and low sample volume requirement [17,18].
Microfluidic devices developed specifically for whole blood detection assays can reduce the
sample preparation time and provide rapid results. This reduction in time from sample to result
is highly desirable in patients with traumatic conditions, including critical illness, perioperative
haemorrhage and severe blood loss due to coagulation abnormalities [19]. The need for rapid results
with reduced turnaround time and microlitre volumes of samples have promoted the use of POC
testing devices in the past few decades [20]. Micro-coagulation systems such as the ACT are employed
in near-patient settings to regulate the heparin dosage during cardiopulmonary bypass surgery. The
ACT test is carried out by introducing a small amount of whole blood into a cartridge preloaded with a
coagulation activator such as celite, kaolin, glass beads, or phospholipids mixture and the clotting time
is derived either mechanically, optically or electrochemically [21].
Most anticoagulants, including heparin and its derivative, low molecular weight heparin
(LMWH), direct factor Xa (FXa), and thrombin inhibitors, are monitored using aPTT or specific
chromogenic/fluorogenic coagulation assays. The aPTT assay was developed to monitor the intrinsic
and common pathways of coagulation and is derived by adding a surface activator with phospholipid
to the plasma sample. The average clotting time obtained from an aPTT assay is in the range of 22 to
40s [14,16]. Innovative approaches in centrifugal microchips and electro-mechanical detection systems
have been developed as high-throughput microfluidic devices that consume microlitre volumes of
sample whole blood and reagents to carry out aPTT tests in near-patient settings [22,23]. Chromogenic
anti FXa assays are also carried out as an alternative to aPTT to measure the concentration of LMWH
and FXa inhibitors based on the enzymatic cleavage of FXa specific substrates in laboratory settings.
Harris et al. developed a microfluidic device incorporated with a miniaturised fluorogenic anti-FXa
assay specifically designed to conduct the quantitative assessment of heparin using a fluorescence
detection system [24]. Such advances in microfluidic technologies are providing a platform to develop
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portable, less labour-intensive and cost-effective devices that can be employed in near-patient settings
as well as for the remote monitoring of CVD [25].
In this review, advanced microfluidic devices are discussed based on their innovative design
specifications, fabrication techniques, and different modes of detection developed for the diagnosis
of haemostasis related disorders and monitoring of antithrombotic therapies. The preferred range of
materials that are used in developing micro-channels are presented and their significance in assay
development is highlighted.
2. Microfluidic Chip Design
Microfluidics offers technology to enable the miniaturisation of biological assays, significantly
impacting high-throughput drug screening applications. The micro-channels are generally small in
cross sectional area, with governing dimensions ranging from micrometres to nanometres. This small
feature size enables the ability to run many samples in parallel. This parallelisation, in conjunction with
the small volumes required for a given test, facilitates high-throughput screening [26]. However, given
the relatively small volumes of fluids required per test, the viscous forces present in the fluid typically
dominate over the inertial forces. This results in a relatively unique set of design considerations. The
efficient design of a microfluidic device is dependent upon the interaction of a number of factors
relating to fluid dynamics at a micro scale. The performance of micro and nano-fluidic devices relies
on an understanding of parameters including fluid velocity, flow rate, pressure gradient, diffusion
coefficients and chemical interactions within the often-complex network of micro-channels [27]. In this
section, the significant design features in accordance with mechanical parameters that are responsible
for appropriate transport of the fluid and accurate mixing of reagents are reviewed.
2.1. Fluid Specific Considerations
2.1.1. Miscible and Immiscible Fluids
In biological applications, an important consideration while designing a microfluidic device is
creating an environment for appropriate mixing of reagents with samples. The fluid flow in the small
channels of a microfluidic device is typically in the laminar regime. A characteristic of laminar flow is
that the mixing of reagents and samples is governed by diffusion rates of the media. This process is
slow relative to the turbulent flow regimes typical in macro-fluidic systems [28]. Different approaches
for achieving the optimized mixing of fluids include various techniques to increase fluid–fluid interface
area, modification of surface chemistries, magnetic stirring, differential pressure, and generating heat
or electric field [29].
Centrifugal-type microfluidic platforms have become popular in recent years. The characteristic
nature of a centrifugal platform is that fluid flow is generated through a pressure differential caused
by rotating the platform at defined speeds. In one such example, a microfluidic disk analyser (MDA)
device was developed to execute the PT test. The device included two sample reservoirs, one for the
application of human plasma and another for the PT reagent. On rotating the platform at a speed
of 5000 rpm for two seconds, efficient mixing was achieved in a 200 mm long serpentine channel.
Figure 1 shows the design of the reservoirs and the micro-channels in which the degree of mixing
can be characterised by the change in colour, as both yellow and blue solutions progress along the
serpentine ‘mixing’ channel towards the detection chamber [30]. With the capability of executing 15
parallel tests and 10 µl of sample with reagent, it proved advantageous compared to the gold standard
benchtop analyser. The gold standard Sysmex CA-1500 cannot perform parallel testing and requires
an order of magnitude more sample and reagent for a single test.
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containment of the assay within a droplet, coupled with the ability to generate significant numbers
of droplets for a given experiment, results in the capacity to generate a significant number of assays
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Figure 3. Schematic representation of droplet-based microfluidic device with a long channel for
Figure 3. Schematic representation of droplet-based microfluidic device with a long channel for
continuous analysis of thrombin generation in real-time. Taken with permission from [33].
continuous analysis of thrombin generation in real-time. Taken with permission from [33].
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2.1.3. Viscosity
Rate of blood flow in the vascular system is a function of viscosity. As the blood coagulates, there
is a major change in its viscoelastic properties [41]. Blood clotting time can be measured by
monitoring the change in viscosity due to the formation of a fibre-like protein, fibrin, during
coagulation. A high-throughput microfluidic device comprised of seven sample wells has been
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2.1.3. Viscosity
Rate of blood flow in the vascular system is a function of viscosity. As the blood coagulates, there
is a major change in its viscoelastic properties [41]. Blood clotting time can be measured by monitoring
the change in viscosity due to the formation of a fibre-like protein, fibrin, during coagulation. A
high-throughput microfluidic device comprised of seven sample wells has been designed to determine
blood coagulation time using blood plasma resistance as a key parameter. The aggregation of red blood
cells and fibrin formation in the blood clot will result in an increase in blood viscosity and solidification
of blood plasma. Each well in the microchip was incorporated with an electrode that can run seven
parallel tests, as shown in Figure 6A. The blood sample of only 10 µL was required to obtain the blood
clotting
time24,
[42].
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(nano-LC) and mass spectrometry to detect inhibitors of two significant enzymes in coagulation, FXa
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2.2. Transduction Methods
LOCs are gaining popularity with their ability to perform multiple reactions in a single
microfluidic device. The advancements in microfabrication technologies allow for the integration of
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and thrombin. This high-resolution screening technique was aimed at identifying enzyme inhibitors
in a precise and rapid manner. The chip of approximately 45mm in length was divided into two
microreactors. The microchannels of the first micro-reactor provided an environment to carry out
the reaction of the enzyme-inhibitor reaction, which was quantified in the presence of a fluorogenic
substrate in the second microreactor. This system provided better screening of the compounds when
compared to the traditional multi-well plate method [45].
Microfluidic device designs can be utilised to create a biological model that can imitate physiological
functions. One such biomimetic microfluidic model comprising all three blood vessels, an artery, a
vein, and few capillaries was designed to represent the human circulatory system. The model was used
to demonstrate the self-repair process in haemostasis with the help of non-biochemical reactions [46].
A novel design concept of introducing a venous valve in a micro-tubular structure allowing blood flow
and clot propagation has also been implemented into a microfluidic device that was developed to study
the intricate haemostasis mechanism [1]. Such creative designs are providing a platform on which to
develop innovative multi-assay near-patient devices for application in the field of haemostasis.
2.2. Transduction Methods
LOCs are gaining popularity with their ability to perform multiple reactions in a single microfluidic
device. The advancements in microfabrication technologies allow for the integration of innovative
LOC devices coupled with efficient detection systems. The nature of the approach used for microfluidic
detection plays a crucial role in improvising the system in terms of its responsiveness, accuracy,
sensitivity, cost-effectiveness, and portability [47–49].
Optical detection techniques using spectroscopic methods such as absorbance, fluorescence and
chemiluminescence are widely used in biological microfluidic applications. Laser-induced fluorescence
(LIF) is a highly sensitive and well-established detection technique for the analysis of various
fluorescence-emitting biomolecules in high throughput microfluidic devices. With advancement in
fabrication techniques for integrating microelectrodes within devices, several methods are used in
biomedical applications to detect different electrical parameters based on applied current/voltage. The
efficient and low-cost production of micro-electrodes has resulted in significant use of electrochemical
techniques [50–52]. Another common detection technique used in microchips designed for application
to proteomics is the integration of the outlet with mass spectrometry (MS) [53]. Apart from the methods
above, other transduction approaches include Nuclear Magnetic Resonance (NMR), Surface Plasmon
Resonance (SPR), Raman spectroscopy, and acoustic wave-dependent detection, incorporated in microand nano-fluidic devices [48,53].
Blood clot formation is a result of a series of biochemical reactions occurring simultaneously that
involves many particles, cells, proteins and other blood components in the process. There are a range
of assays developed for monitoring antithrombotic therapies and diagnosing underlying haemostatic
disorders. These assays are designed in accordance with particular blood components specific to their
application. Micro-analytical devices based on these assays either have integrated sensors [54] or
separate detection systems based on the electrical [55], acoustic [56], mechanical [57], rheological [58]
or optical [59] properties of coagulated blood.
2.2.1. Electrical Impedance Dependent Detection Techniques
Since 1948, it has been demonstrated by a series of experiments that blood clotting causes
continuous changes in blood impedance. The change in impedance is related to the fibrinogen
concentration in plasma. The formation of fibrin and platelet accumulation is directly proportional
to an increase in impedance during the initial stage of coagulation, whereas, in the later phase of
clot retraction, there is a decrease in the impedance value [60–62]. Electrochemical impedance can be
used to accurately determine the clotting time of blood under controlled voltage and temperature
conditions [63,64].
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conditions [63,64].
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2.2.2. Optical Detection Method
Microscopic Methods
Fluorescence microscopy is the most preferable detection technique used in crucial studies of
biomolecules and cellular components, as well as living cells [67]. Recently, Paiè et al. [68] published
a detailed review article describing advancements in the fluorescence microscopic techniques used
in next generation microfluidic devices newly termed as Microscopes-on-Chip (MOC). Bright-field
microscopy enabled with high-speed cameras is one of the most common detection techniques used to
study the physical properties and dynamic behaviour of droplets formed in the micro-channels [49].
An application of bright-field microscopy in combination with fluorescence microscopy was employed
to study the effect of argatroban, a direct thrombin inhibitor, on aPTT in a plug based microfluidic
device. A series of images of a single plug travelling throughout the micro-channel were captured
using bright-field microscopy and the quantitative measurement of thrombin generation was carried
out using fluorescence microscopy. The analysis of the collective images displayed a clot in the form of
a dark spot in the middle of the plug resulting from red blood cells (RBCs) suspended within the fibrin
trap, as shown in Figure 8 at the 136 s time interval. aPTT was derived from the time taken to obtain
the dark spot as well as the increase in fluorescence intensity with high thrombin production during
coagulation [32].

captured using bright-field microscopy and the quantitative measurement of thrombin generation
was carried out using fluorescence microscopy. The analysis of the collective images displayed a clot
in the form of a dark spot in the middle of the plug resulting from red blood cells (RBCs) suspended
within the fibrin trap, as shown in Figure 8 at the 136 s time interval. aPTT was derived from the time
taken
to 2020,
obtain
the dark spot as well as the increase in fluorescence intensity with high thrombin
Molecules
25, 833
10 of 31
production during coagulation [32].

Figure
imageanalysis
analysisofofa asingle
singleplug
plug
representing
formation
of the
Figure 8.
8. Bright-field
Bright-field microscopic
microscopic image
representing
thethe
formation
of the
clot
clot
through
a dark
respect
to time.
Taken
permission
through
a dark
spotspot
withwith
respect
to time.
Taken
withwith
permission
fromfrom
[32].[32].

In one
fluorescence
microscopy
was used
demonstrate
the dynamic
In
one study,
study,time-lapse
time-lapse
fluorescence
microscopy
was toused
to demonstrate
the behaviour
dynamic
of blood clot
entire length
a micro-channel
diseased
vascular
behaviour
of formation
blood clotthroughout
formationan
throughout
anofentire
length of amimicking
micro-channel
mimicking
regions. The
resultsregions.
obtained The
after the
continuous
monitoring
thrombus formation
usingoffluorescently
diseased
vascular
results
obtained
after theof continuous
monitoring
thrombus
labelled fibrinogen
and plateletlabelled
imagingfibrinogen
could be correlated
to in
vivo thrombus
formation
using fluorescently
and platelet
imaging
could beformation
correlatedintostenosed
in vivo
(narrowed)
arterioles.
These results
were arterioles.
further processed
to obtain
clotting
time [39].
The
thrombus
formation
in stenosed
(narrowed)
These results
were the
further
processed
to obtain
microfluidic
channel
in the biomimetic
device
was fabricated
using PDMS.
This
the
clotting time
[39].network
The microfluidic
channel microfluidic
network in the
biomimetic
microfluidic
device was
channel network
was then
tonetwork
a standard
slide. The
dynamicscover
of platelet
fabricated
using PDMS.
Thissealed
channel
wasmicroscope
then sealedcover
to a standard
microscope
slide.
aggregation
under
flow through
this channel
network
thenthis
be interrogated
using epi-fluorescence
The
dynamics
of platelet
aggregation
under
flow could
through
channel network
could then be
microscopy. The
image
processing of microscopy.
fluorescently The
labelled
platelets
demonstrated
the progression
of
interrogated
using
epi-fluorescence
image
processing
of fluorescently
labelled
platelet aggregation
similar
to in vivo micro-vascular
networks and
alsoto
concluded
that the device
platelets
demonstrated
the progression
of platelet aggregation
similar
in vivo micro-vascular
could be and
usedalso
for concluded
analysis ofthat
platelets
in varying
shear
rate
[69]. The
fluorescence
networks
the device
could be
used
forenvironments
analysis of platelets
in varying
shear
microscopic
detection
method
has
been
used
by
several
groups
to
study
shear
rate-dependent
analysis
rate environments [69]. The fluorescence microscopic detection method has been used by several
of blood
including platelets,
tissue
factor,components
and complex
vascular
deformation
groups
to components
study shear rate-dependent
analysis
of blood
including
platelets,
tissue during
factor,
thrombosis, using novel designs in microfluidic devices [34,40,70–72].
Non-Microscopic Optical Methods
The cost-effective detection of bio-analytes is becoming increasingly popular, with leading edge
techniques enabling the integration of optical detectors in microfluidic devices. Novel developments in
fabricating the nano- and microdevices with lens-less microscope detection systems was discussed in
depth by Pires et al. This is achieved by employing optical sensors, including complementary
metal-oxide-semiconductors (CMOSs), charged-coupled devices (CCDs), lasers and filters [47].
Smartphone cameras and desktop scanners have made it possible to capture and transmit almost
real-time images from an off-site centre to the experts for analysis. This ability to capture and store
images for analysis is becoming increasingly popular. One area where this is particularly true is
where colorimetric assays are employed. CMOSs, typically used in smart phone type devices, have
significantly improved their signal-to-noise ratio in recent years, so much so that both quantitative and
qualitative assays can be carried out [73].
Li et al. demonstrated a microscope-free detection technique to study platelet aggregation at
multiple shear rates by integrating a laser diode, filters, and CCD sensor in a micro-device fabricated
with PDMS, as depicted in Figure 9A. The results, in terms of increase in light intensity during platelet
aggregation using this novel optical detection system, were highly correlated with the outcomes of
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A different application of a smartphone detection system is schematically represented in Figure 9C.
In this system, a paper-on-PDMS device was fabricated to immobilise quantum dots (QDs) conjugated
to a fluorophore (Alexa Fluor 647-maleimide) labelled peptide substrate specific for thrombin. Upon
excitation with LEDs, the fluorescence emitted following the cleavage of fluorophore in the presence
of thrombin was captured by the smartphone camera. The variations in fluorescence intensity were
processed in the form of a series of images to evaluate the amount of thrombin in whole blood [76].
A high-throughput microfluidic paper analytical device (µPAD) comprised of eight channels was
developed to determine the concentration of direct thrombin inhibitors in the presence of the ecarin
clotting chromogenic assay (ECA) using smartphone camera images as a mode of detection. The
observations from the processed images demonstrated an elevated absorbance value when correlated
with the standard spectrometer measurements, with ambient lighting conditions a possible causative
factor [77]. It is envisaged that with more sophisticated image processing techniques, any discrepancy
due to ambient lighting conditions would be eradicated.
2.2.3. Mechanical Detection Methods
Blood coagulation leads to an increase in blood viscosity. This mechanical parameter can be
analysed using MEMS-based mechanical sensors, often using resonance frequencies to infer the
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3.1. Materials for Device Fabrication
Microfabrication technologies began as a result of the significant drive towards the miniaturisation
of integrated circuits in the microelectronics industry. As such, these technologies were typically focused
on silicon materials. As these technologies transitioned to LOC-type devices, they were applied to glass
due to the similarities in properties with silicon and the fact that existing laboratory techniques were
well established using glassware. Both silicon and glass have some desirable mechanical properties
such as high thermostability, solvent compatibility and stable surface charge. Further technologies are
well established to enable construction of nano-channels less than 100 nm [81,82]. A major limitation
of silicon and glass devices is the typical cost of manufacture at mass production volumes. Other
challenges, such as issues around the disposal of glass-based devices, have resulted in alternative
materials such as polymers, elastomers, plastics, and paper being used to fabricate LOC devices [83].
With the introduction of these new materials came additional fabrication techniques.
Among the more common materials used in the development of microfluidic and high throughput
coagulation related devices is polydimethylsiloxane (PDMS). This material has become favourable
due to its optical transparency, low-temperature curing, non-toxicity, reversible deformity, and
smoothness [84,85]. The high porosity of PDMS also facilitates air permeability, a potentially desirable
factor for biological applications including cell culture-mediated devices [86]. One such example of a
microfluidic device using eight parallel test chambers to study the importance of platelet adhesion
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in haemostasis was developed using PDMS. The selection of PDMS as a material for this study was
based on its property of non-specific adsorption and ease in fabrication, where it was observed that
blood platelets attach to only specific factors in the blood but do not adhere to the walls of PDMS
device [12]. Zhang et al. developed a microfluidic device to demonstrate the reduction in thrombus
formation during blood flow experiments. This was achieved by modifying the surface properties of
PDMS through polymerisation with sulfobetaine monomer. The modified PDMS showed minimal
attachment of plasma proteins, hence reducing clot formation within the device. This technique
could be implemented in scenarios where unobstructed whole blood movement is desired, such as
dialysis [87].
PDMS is widely used in prototype microfluidic device fabrication. Fabrication is typically carried
out using a soft lithography technique where the high compliance of the elastomer has made it
possible to develop complex microstructures. Though PDMS has been widely used, there are some
limitations. PDMS is limited in terms of its use with all organic solvents, restricting its use in some
applications [82]. The low stiffness of PDMS can lead to micro-channel deformation, making it
unsuitable for high-pressure fluidic applications. An undesirable absorption of molecules in PDMS
further adds to its limitations in various cell culture-based micro-devices [88,89]. Although the
process of modifying PDMS resulting in compatibility with a desired application may overcome these
limitations, researchers also utilise other materials to enable LOC devices. Among the more common
of these materials are thermoplastics.
Thermoplastics are widely used in industrial applications because of their easy availability and
cost-effective mass production. Polymethylmethacrylate (PMMA), polyvinyl chloride (PVC), cyclic
olefin polymer (COC/COP) and polystyrene (PS) are some of the thermoplastics that exhibit good
mechanical strength, rigidity, thermal stability, and relative chemical/biological inertness, and are
commonly used in microfluidic devices [90]. The large-volume manufacturing of micro-devices using
plastic can be achieved by well-established fabrication techniques such as injection moulding and
casting, which further adds to its marketability [91]. Significant work has been carried out on a range of
thermoplastics in terms of surface modifications to promote specific binding of a given target molecule.
Given the mechanical robustness and relative ease of fabrication, additional functionality such as
pumps, valves and sensors can, in some cases, be incorporated as part of the LOC device itself [82].
A PMMA-based microfluidic dielectric sensor device was designed and fabricated to monitor whole
blood coagulation time using the principle of dielectric spectroscopy (DS). DS was used to monitor the
temporal variation in the permittivity of blood as a function of frequency. Sensing electrodes deposited
on the biomedical grade PMMA measured the permittivity of blood during the clotting phase using
only 9µl of the sample blood [92].
Over the past decade, there has been a surge in paper-based microfluidics, which have significant
potential for application to biomedical diagnostics [93]. Paper contains cellulose as a key component
and possesses advantages in terms of its distinct properties, such as being lightweight, inexpensive,
readily accessible and can be chemically modified to enhance its biological compatibility for integrating
different functional groups to it [94,95]. Recently, a paper-based diagnostic micro-device was developed
to study blood viscosity and coagulation time that costs less than 50 cents per device [75]. A unique
combination of paper on PDMS, as discussed earlier, was used to develop a microfluidic device
for a POC application. The nitrocellulose paper was modified using a series of reactions for the
immobilisation of quantum dots with peptide conjugates and fluorophore [76].
Material selection plays an enormous role in driving the fluid mechanisms of a microfluidic
device. An appropriate selection of a material for the desired application is conditional to several
factors, including flexibility, biological and chemical compatibility and surface properties [81,96].
While inherent mechanical properties of the material aid in the selection of the microchip fabrication
technique, the optical/electrical properties of the material determine the type of detection method to
be used.
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3.2. Fabrication Techniques
Fabrication approaches are highly influenced by the type of material used to develop a device
and the inherent properties of that material. Semiconductor materials like silicon-based devices can
be fabricated using photolithography [97], which can further be used to fabricate polymeric devices
using casting, injection molding [98], embossing, and imprinting techniques [99], while glass-based
devices are produced by deep UV photolithography [100] and wet and dry etching methods [101].
With an increase in demand for disposable microfluidic devices in near-patient settings, cost-effective
technologies, such as soft lithography, for developing polymeric micro and nano-chips have increased
in the past two decades [102,103]. Laser-based micromachining techniques are also used for fabricating
low-cost devices from thermoplastics [104]. In the past few years, µPADs, also termed as microfluidic
paper-based analytical devices, have been gaining popularity because of their convenient accessibility
and affordability. Solid wax and inkjet printing are high-throughput fabrication techniques that can
significantly scale up the micro-patterning of µPADs [105,106].
3.2.1. Direct Machining
Photolithography
Photolithography is a common technique used in the development of microfluidic devices. It is a
type of lithography that uses light to project a pre-designed pattern on to the desired material [107].
The first step in microfabrication with photolithography is to construct a photomask from the pattern
of desired microchannels and typically created using design software [100]. Photomasks, generally
made of quartz, are developed using techniques such as electron beam lithography and laser beam
ablation [108,109]. The solid substrate, such as silicon or glass, is coated with a layer of photoresist.
A photoresist is a photosensitive polymer responsible for the formation of shape and depth of
microchannels [110]. In the presence of an ultraviolet (UV) light source, the pattern on a photomask is
then transferred to the photoresist coated over the substrate. The final step involves the baking and
chemical treatment of the substrate to develop the master template. The positive or negative moulds of
the substrate can be obtained depending on the type of photoresist used in the fabrication process, as
depicted
in Figure
11 [111].
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SU-8 is an epoxy-based photoresist material widely used in microfluidic chip development. It
can be spin-coated to form a layer over the substrate that will outline the microchannel of desired
depth and pattern upon application of UV energy through the photomask [110,112,113]. SU-8 UV
photolithography was used to create a microvascular structure on silicon wafers to study the
mechanical properties and geometry of blood vessels during thrombosis and other vascular diseases
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SU-8 is an epoxy-based photoresist material widely used in microfluidic chip development. It
can be spin-coated to form a layer over the substrate that will outline the microchannel of desired
depth and pattern upon application of UV energy through the photomask [110,112,113]. SU-8 UV
photolithography was used to create a microvascular structure on silicon wafers to study the mechanical
properties and geometry of blood vessels during thrombosis and other vascular diseases [34].
Chemical Etching
Silicon and glass patterning for the development of microfluidic devices can also be carried out
through chemical etching. Chemical etching performed in the presence of a strong acid is referred
as wet etching. Dry etching is carried out by reactive-ion etching (RIE) in the presence of plasma
generated through an electromagnetic field. The reactive ions formed by plasma will carry physical
etching to the exposed surface and form micro-patterns on glass as well as silicon. The process of
dry etching is comparatively more time consuming as it is dependent on multiple factors, including
plasma density, selected gas composition, applied voltage, temperature gradients generated on the
substrates, and pressure in the source chamber [113–115].
Microchannel formation in conjunction with electrode integration within the microfluidic devices
can be conducted with high precision through chemical etching combined with photolithography. This
method involves standard photolithography followed by wet metal etching in the presence of an acid,
such as hydrofluoric acid (HF) or hydrochloric acid (HCL). Cr/Au is one of the most effective etching
layers for the micro-patterning of glass that can withstand high acidic conditions without forming
any defects on the substrate [113,116,117]. A POC microfluidic device for measuring aPTT of whole
blood using the principle of change in electrical impedance was integrated with 100 µm-wide Cr/Au
electrodes using a wet etching technique. The fabrication of the device was carried out using two
different molds, one based on glass wafer for electrode deposition and other based on a silicon wafer
for microchannel formation using PDMS, and they were bonded together using thermal treatment, as
shown in Figure 12A. This microfluidic device with a channel height of 100 µm was developed using a
deep reactive ion etching (DRIE) technique. DRIE was used to create deep penetration by selective
Molecules
24, xsacrificial layer of the silicon to develop the master template [22].
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in Figure 12B (a) Photolithography. The uncured photoresist is then washed away, and the exposed
in Figure 12B (a) Photolithography. The uncured photoresist is then washed away, and the exposed
Ti/Al substrate is etched, leaving only Ti/Al patterns under the cured photoresist. Finally, the cured
Ti/Al substrate is etched, leaving only Ti/Al patterns under the cured photoresist. Finally, the cured
resist is removed, and the final electrode pattern will stay on the glass substrate [42]. In addition to
the aforementioned devices, a microfluidic dielectric sensor for obtaining blood clotting time using
whole blood permittivity was fabricated with Ti/Au electrodes. An indirect etching technique defined
as a lift-off process was employed to integrate the electrodes on selected regions of PMMA in which
the Ti/Au was sputtered after the etching process [92].
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resist is removed, and the final electrode pattern will stay on the glass substrate [42]. In addition to the
aforementioned devices, a microfluidic dielectric sensor for obtaining blood clotting time using whole
blood permittivity was fabricated with Ti/Au electrodes. An indirect etching technique defined as a
lift-off process was employed to integrate the electrodes on selected regions of PMMA in which the
Ti/Au was sputtered after the etching process [92].
Injection Moulding and Laser Processing
Thermoplastics are relatively easy to fabricate compared to the conventional silicon or glass-based
devices and are more robust than elastomers such as PDMS. Injection moulding is a straightforward
technique now being applied to fabricate micro- and nanofluidic devices [99]. In the injection moulding
process, granules of a given thermoplastic are fed into the injection barrel and heated to beyond the
melting point of the given thermoplastic. The melted material is injected into the pre-designed mould at
relatively high pressure and allowed to cool down to take the shape of the desired micro-device [98,118].
Rapid prototyping of thermoplastics can be also be carried out by laser micromachining. This
technology can produce a number of microfluidic devices of different designs without the requirement
for master moulds [104]. A laser beam projected towards a given substrate such as thermoplastic,
metal, polymer, ceramic or glass creates a cavity either photo-chemically or photo-thermally or by the
combination of both. The precisely controlled fabrication of microchannels can be achieved by different
fine-tuning parameters like laser power, moving speed of the laser beam, and distance between the
substrate and the laser system [119].
An example of the fabrication and assembly of a high throughput microfluidic device is shown in
Figure 13. This device was made of PMMA, PC and a double adhesive tape. The microchannels on the
double adhesive tape were patterned using laser micromachining technique and it was adhered to the
PMMA and PC layers. The device was fixed with permanent magnets in the bottom to capture the
magnetic beads in the thrombin detection assay. Two thrombin binding aptamers were coated with
magnetic beads and QDs, respectively. The detection of thrombin in the blood from the mixture of
the other coagulation proteins was carried out by detecting the fluorescence generated by QDs. The
permanent magnet was used to retain the thrombin attached to the magnetic beads during several
washing steps throughout the entire assay [120]. Another microfluidic disk was fabricated using
PMMA and polyethylene terephthalate (PET) to analyse PT using 14 µL of whole blood. Injection
moulding was used to develop a 600 µm thick PMMA disk which was bonded with the PET lid
using pressure sensitive adhesive (PSA). The centrifugal microfluidic disk could separate platelet poor
plasma (PPP) from whole blood in the first stage of the test assay. The PPP thus obtained reacted with
the PT reagent in the second stage to carry out further INR measurements [121].
Laminate-based and Printing Techniques
Among the simplest methods for fabricating microfluidic devices is to bind independent layers
together by means of lamination. The overall steps for manufacturing laminated devices include the
selection of the material, formation of desired features on individual layers through conventional
methods such as cutting, machining or laser processing and subsequent bonding of appropriately
aligned layers in a cleanroom type facility [122]. Based on the properties of the selected material,
the binding can be performed using either an adhesive or a thermal mode of bonding. Thermal
bonding is conducted by applying pressure to the layers that are pre-heated just beyond their glass
transition temperature (Tg). Paper-based microfluidic analytical devices are developed using thermal
bonding lamination, where the paper-microchip is sealed between the polyester lamination films
when processed through the heated laminator [123]. Low cost and higher scalability are the primary
advantages of the laminated-based production of micro and nanodevices.
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Laminate-based
and of
Printing
techniques
The fabrication
biological
analytical devices based on paper-based microfluidics technology
started more than a decade ago, using approaches like photolithography, laser treatment, plasma
Among the simplest methods for fabricating microfluidic devices is to bind independent layers
treatment, etching techniques, and several printing methods including wax printing and inkjet printing.
together by means of lamination. The overall steps for manufacturing laminated devices include the
Li et al. (2012) discussed these techniques in detail in a paper-based microfluidic review article [105,124].
selection of the material, formation of desired features on individual layers through conventional
Cellulose fibres in paper are hydrophilic, on which selective hydrophobic reagents can be added
methods such as cutting, machining or laser processing and subsequent bonding of appropriately
to create a pattern of hydrophilic-hydrophobic micro-channels throughout the entire chip length.
aligned layers in a cleanroom type facility [122]. Based on the properties of the selected material, the
The hydrophobic boundary of the microchannel confines the sample and reagents and leads to the
binding can be performed using either an adhesive or a thermal mode of bonding. Thermal bonding
capillary movement within the channel [125]. The printing methods for fabrication of µPADs include
is conducted by applying pressure to the layers that are pre-heated just beyond their glass transition
heated hydrophobic solid wax deposition in wax printing [126], polystyrene impregnation on paper in
temperature (Tg). Paper-based microfluidic analytical devices are developed using thermal bonding
flexographic printing, deposition of electrodes, and the alteration of the chemical composition of paper
lamination, where the paper-microchip is sealed between the polyester lamination films when
using alkyl ketene dimer (AKD) in inkjet printing [127].
processed through the heated laminator [123]. Low cost and higher scalability are the primary
Wax printing is an inexpensive and quick method that can produce approximately 100-200 µPADs
advantages of the laminated-based production of micro and nanodevices.
in a single batch, making it suitable for various analytical and diagnostic biomedical applications [126].
The fabrication of biological analytical devices based on paper-based microfluidics technology
A solid wax printer was used to fabricate a µPAD designed for separating plasma from whole blood.
started more than a decade ago, using approaches like photolithography, laser treatment, plasma
The solid wax was melted on the chromatography paper, creating a 1mm thick hydrophobic wall
treatment, etching techniques, and several printing methods including wax printing and inkjet
throughout the test region, as shown in Figure 14. The separation procedure involved the agglutination
printing. Li et al. (2012) discussed these techniques in detail in a paper-based microfluidic review
of RBCs in the centre spotted with antibodies (anti-A,B) and the transportation of plasma using capillary
article [105,124]. Cellulose fibres in paper are hydrophilic, on which selective hydrophobic reagents
action in the lateral zones of the paper strip [128]. This simple microfluidic device could be used to
can be added to create a pattern of hydrophilic-hydrophobic micro-channels throughout the entire
develop plasma-based blood coagulation monitoring assays which will further reduce the laboratory
chip length. The hydrophobic boundary of the microchannel confines the sample and reagents and
sample preparation stages.
leads to the capillary movement within the channel [125]. The printing methods for fabrication of
µPADs include heated hydrophobic solid wax deposition in wax printing [126], polystyrene
impregnation on paper in flexographic printing, deposition of electrodes, and the alteration of the
chemical composition of paper using alkyl ketene dimer (AKD) in inkjet printing [127].
Wax printing is an inexpensive and quick method that can produce approximately 100-200
µPADs in a single batch, making it suitable for various analytical and diagnostic biomedical
applications [126]. A solid wax printer was used to fabricate a µPAD designed for separating plasma

from whole blood. The solid wax was melted on the chromatography paper, creating a 1mm thick
hydrophobic wall throughout the test region, as shown in Figure 14. The separation procedure
involved the agglutination of RBCs in the centre spotted with antibodies (anti-A,B) and the
transportation of plasma using capillary action in the lateral zones of the paper strip [128]. This simple
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polymeric material that can seal to different substrates, either reversibly or irreversibly, depending
Inapplication
one application,
on the
[131].a brass mould was used to cure PDMS to fabricate a 2.5mm thick device with a
central hole. This device was further treated with oxygen plasma to achieve a permanent bonding with
a glass coverslip to enhance the acoustic contact when placed over the surface acoustic wave (SAW)
transducer. The novel device uses the principle of SAW-induced mixing of sample blood with assay
reagents including fluorescent microspheres. The clotting time was derived from the time taken by the
rapid tumbling of the fluorescent microspheres to cease as the clot formation progresses [132].
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Figure 15. Schematic representation of micro-channel fabrication using soft lithography. (A) A highFigure
15. Schematic representation of micro-channel fabrication using soft lithography. (A) A
resolution transparency containing the design of the channels, created in a CAD program, was used
high-resolution transparency containing the design of the channels, created in a CAD program, was
as the mask in photolithography to produce a positive relief of photoresist on a silicon wafer. The
used as the mask in photolithography to produce a positive relief of photoresist on a silicon wafer. The
scale bar gives an indication of the thickness and width of photoresist. (B) Glass posts were placed on
scale bar gives an indication of the thickness and width of photoresist. (B) Glass posts were placed on
the wafer to define reservoirs for analytes and buffers. (C) A prepolymer of PDMS was then cast onto
the wafer to define reservoirs for analytes and buffers. (C) A prepolymer of PDMS was then cast onto
the silicon wafer and cured at 65 °C for 1 h. (D) The polymer replica of the master containing a
the silicon wafer and cured at 65 ◦ C for 1 h. (D) The polymer replica of the master containing a negative
negative relief of channels was peeled away from the silicon wafer, and the glass posts were removed.
relief of channels was peeled away from the silicon wafer, and the glass posts were removed. (E) The
(E) The PDMS replica and a flat slab of PDMS were oxidized in a plasma discharge for 1 min. Plasma
PDMS replica and a flat slab of PDMS were oxidized in a plasma discharge for 1 min. Plasma oxidation
oxidation had two effects. First, when two oxidized PDMS surfaces were brought into conformal
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A microfluidic haemostasis model consisting of eight inlets and a single outlet channel was cast
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Biomolecule patterning is a technique for immobilizing biomolecules to a substrate. One of the
common methods for patterning proteins within a specific location on microfluidic devices is deep
UV photolithography. The technique was adopted from the field of microelectronics where it was
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single channel. This device was vacuum bonded onto a glass slide and 5 µL of the collagen sample
single channel. This device was vacuum bonded onto a glass slide and 5 µL of the collagen sample
was injected into the microchannel. Thus, collagen formed a thin layer over the glass slide, over which
was injected into the microchannel. Thus, collagen formed a thin layer over the glass slide, over which
the fluorescently labelled kaolin was coated. The concentration of collagen/kaolin covering the
the fluorescently labelled kaolin was coated. The concentration of collagen/kaolin covering the surface
surface of the device was evaluated using the Image J software based on the fluorescence intensity
of the device was evaluated using the Image J software based on the fluorescence intensity [135] and
[135] and the contact activation of clotting in a controlled microfluidic device analysed.
the contact activation of clotting in a controlled microfluidic device analysed.

Figure 16. Experimental set-up: Collagen/kaolin patterned to a glass slide with a thickness of 250
Figure 16. Experimental set-up: Collagen/kaolin patterned to a glass slide with a thickness of 250 µm.
µm. The microfluidic device with 8 inlets was then bonded to the glass slide. Taken with permission
The microfluidic device with 8 inlets was then bonded to the glass slide. Taken with permission from
from [135].
[135].
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POC devices have significantly increased the quality of clinical care in terms of rapid diagnostic
POC devices have significantly increased the quality of clinical care in terms of rapid diagnostic
test results, increased flexibility, and reduced laboratory processing time. The global market share of
test results, increased flexibility, and reduced laboratory processing time. The global market share of
POC devices is expected to reach USD 38.1 billion by 2022, with a compound annual growth rate of
POC devices is expected to reach USD 38.1 billion by 2022, with a compound annual growth rate of
10%, of which majority of the devices are based on lateral flow assays [136]. With advancements in
10%, of which majority of the devices are based on lateral flow assays [136]. With advancements in
microfluidictechnology,
technology,LOC-based
LOC-based
research
is progressing
to develop
next-generation
devices.
microfluidic
research
is progressing
to develop
next-generation
POC POC
devices.
Chin
et
al.
have
descriptively
summarised
the
market
analysis
of
microfluidic
POC
devices
Chin et al. have descriptively summarised the market analysis of microfluidic POC devices and listed and
listed
the companies
have successfully
microfluidic
devices
for blood analysis,
biochemistry
the
companies
that havethat
successfully
developeddeveloped
microfluidic
devices for blood
biochemistry
analysis,
immunoassays,
cardiac
biomarkers,
infectious
disease
tests,
pregnancy-related
analysis,
immunoassays, cardiac biomarkers, infectious disease tests, pregnancy-related analysis, and
others and
others [137]. Table 1 outlines the features and detection methods for the commercially available devices
reviewed in this section.
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Table 1. Features detection methods and for a selection of commercially available coagulation monitoring devices.
PT/INR Monitoring Devices
Device

Features

Detection Method

Coumatrak (Biotrack, USA)
Ciba Corning Biotrack 512 (Ciba Corning Diagnostics, USA)

First Generation Device
First Generation Device
Second Generation small-sized handheld Devices
Integrated with test strip quality check feature
Test cartridge integrated with sensors
Recalled in 2016 for erroneous results
Test cuvettes with micro-channels
Integrated quality control system
Direct clot detection technology
Test chip with one inlet and two micro-channels (Control and PT time
test channel)
Pressure-driven clot formation and detection microchannel cuvette
MEMS-base
Optical-magnetic mode of detection
Test strip consists of an electrochemical cell

Optical
Optical

CoaguChek Series (Roche Diagnostics, Switzerland)
iSTAT®

PT/INR (Abbott Laboratories, USA)
INRatio/INRatio® 2 (Alere Inc., USA)

ProTime® Microcoagulation (International Technidyne Corp, USA)
Coag-Sense™ PT/INR Monitoring System (CoaguSense, Inc., USA)
MicroINR® (iLine Microsystems S.L, Spain)
ProTime InRhythm™ (International Technidyne Corp, USA)
CoagLite® and CoagMax® (Microvisk Technologies, UK)
Bio-AMD’s COAG (Bio-Alternative Medical Devices Ltd., UK)
Xprecia Stride™ Coagulation System (Siemens Healthineers, Germany)

Electro-chemical
Electro-chemical
Electro-mechanical (Electrical Impedance)
Optical
Optical-mechanical
Optical
Mechanical
Electro-mechanical
Optical
Electro-chemical

ACT/aPTT Monitoring Devices
Device
Hemochron Series (International Technidyne Corp, USA)
HMS plus and ACT plus (Medtronic, USA)
iSTAT (Abbott Laboratories, USA)
Cascade POC and Actalyke® series (Helena Laboratories POC, USA)
GEM®

PCL Plus (Instrumentation Laboratory, USA)

Features

Detection Method

Test method – Test tube containing magnet and Test cuvettes preloaded
with celite/kaolin/silica
Heparin Dosage Response assay

Mechanical (First generation devices)
Optical (Second generation devices)
Optical

Multi-test analyser including PT/INR test with ACT and aPTT

Electro-chemical

Cascade POC - Paramagnetic particles-based assay
Actalyke XL – Two-point clot detection technique
Multi-test device for PT/INR, ACT and aPTT monitoring

Optical-Mechanical
Optical

Platelet Function Analysers
Device

Features

Detection Method

Multiplate® (Roche Diagnostics, Switzerland)

Impedance aggregometry and platelet reactivity assays
Platelet aggregation and platelet reactivity monitoring based on platelet
counts
Flow based assay system
Shear stress dependent platelet adhesion monitoring
Electromagnetic induced mixing of sample and reagents

Electromechanical (Electrical Impedance)

PlateletWorks® (Helena Laboratories POC, USA)
PFA-100/200 (Siemens Corporation, USA)
IMPACT-R Cone and Plate (Let) Analyser (DiaMed, Switzerland)
VerifyNow (Accumetrics, USA)
TEG® (Haemonetics Corp., USA)
ROTEM® (Pentapharm GmbH, Germany)
Sonoclot Analyser (Sienco Inc., USA)

Detailed Analysis of blood clot formation and lysis based on viscoelastic
properties of blood

Electromechanical (Electrical Impedance)
Mechanical
Optical
Optical
Mechanical
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Coumatrak by Biotrack (Fremont, CA, USA) and Ciba Corning Biotrack 512 (Medfield, MA, USA)
were among the first-generation coagulation (PT/INR) monitoring devices used in near-patient settings.
The devices were comprised of a monitor with an optical detection system and a test cartridge with a
channel through which the whole blood sample is drawn to the underlying dried reagent via capillary
action. The values of PT and INR were displayed on the monitor based on the clotting time, and the
devices were widely used in patient self-management of warfarin [138,139]. The second-generation
POC devices for monitoring PT/INR were designed by Roche Diagnostics (Basel, Switzerland) and
included the CoaguChek series, of which CoaguChek and CoaguChek S were replaced with the
advanced version CoaguChek XS, a small-sized handheld device. This device works on the principle
of electrochemical detection in which the clotting time is derived from the electrical signal generated by
an electrochemical agent released in the presence of thrombin at the time of clotting. The CoaguChek
XS system also incorporates an integrated quality check feature to ensure the integrity of each test
strip in the event of exposure to high temperature, light or humidity [140]. The iSTAT® PT/INR
(Abbott Laboratories, Chicago, III, USA) system works on the same electrochemical detection principle
and consists of a microfluidic test cartridge integrated with sensors. In one study conducted at an
anticoagulation clinic, PT/INR values of 52 patients on warfarin when measured using iSTAT PT/INR
and CoaguChek XS Plus were compared with the STAGO system, a laboratory-based coagulation
analyser. The results obtained from this small population study demonstrated that CoaguChek XS Plus
is more accurate, but both the devices displayed certain deviation from standard laboratory values [141].
The electrical impedance-based detection method was employed in the INRatio/INRatio2® (Alere Inc.,
Waltham, MA, USA) system for PT/INR monitoring but the device was recalled by the manufacturer in
2016 as it gave a significantly lower INR value than the laboratory measurements [142].
The ITC ProTime® Microcoagulation (International Technidyne Corp (ITC), Edison, NJ, USA)
system is a handheld battery-operated PT/INR monitoring system comprised of cuvettes with
micro-channels, an optical detection system with an array of LEDs and an integrated quality control
system. The INR value is obtained from the clotting time derived by detecting the cessation of the blood
flow with the progression in clot formation in the micro-channel. A multicentre study demonstrated
that the accuracy of ProTime® Microcoagulation system is equivalent to the standard laboratory
plasma test [143]. The Coag-Sense™ PT/INR Monitoring System (CoaguSense, Inc., Fremont, CA, USA)
employs direct clot technology and has a unique combination of test strips with wheel-like appearance
and optical-mechanical mode of detection that uses a laser beam on the periphery of a rotating wheel. In
one single-centre study, two novel POC devices, MicroINR® (iLine Microsystems S.L, Gipuzkoa, Spain)
and ProTime InRhythm™ (ITC, Edison, NJ, USA), were used to demonstrate the INR accuracy along
with existing POC devices (CoaguChek XS and INRatio2 system). MicroINR® (iLine Microsystems S.L,
Gipuzkoa, Spain) is a hand-held PT/INR monitoring device designed for professional use, self-testing,
and self-management. The device consists of a portable analyser, disposable test chip comprising
of two micro-channels one a reaction chamber, and the other an internal control system. A POC
device specifically designed for PT/INR and based on pressure-dependent detection is the ProTime
InRhythm™ (ITC, Edison, NJ, USA). The test cuvettes include micro-channels where clot detection is
performed in duplicate. The blood from the sample chamber is drawn into the micro-channels, where
it is mixed with the reagents through continuous pumping and increasing the pressure on the channel
with the progression of clot formation [144]. A few other POC devices for PT/INR monitoring are
CoagLite® and CoagMax® (Microvisk Technologies, Saint, Asaph, UK) and Bio-AMD’s COAG (BioAlternative Medical Devices Ltd., Warrington, UK) [145]. In 2016, Xprecia Stride (Siemens Healthineers,
Erlangen, Germany), a new handheld PT/INR device was given clearance by FDA. In a recent study,
the Xprecia Stride was compared to the standard laboratory method and the CoaguChek POC device
(ITC, Edison, NJ, USA). The PT/INR resulted in a correlation of 87% with the laboratory method and
93% with CoaguChek devices within 0.5 INR units of each other [146].
The Hemochron series (ITC, Edison, NJ, USA) of automated coagulation monitoring systems have
long been available for regulating high doses of heparin during cardiac surgeries. The first generation
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of Hemochron devices used for measuring ACT was based on the mechanical model of detection in
which the clotting time was derived from the time of the coagulation-induced displacement of a magnet
in the test tube. The newer generation devices (Hemochron Jr® series) are based on optical detection,
employing a series of LEDs and long-range cuvettes such as ACT+ and ACT-LR [21]. Medtronic
(Minneapolis, MN, USA) offers two coagulation systems: the haemostasis management system (HMS
plus) and the automated coagulation timer system (ACT plus). HMS plus/kaolin-ACT system is
designed to measure the heparin concentration by means of a heparin dosage response (HDR) assay
and an optical detection technique. In a recent study, the concentration of heparin in post-reperfusion
circulating blood after the liver transplantation obtained using HMS plus was compared against the
laboratory standard anti-Xa assay. The results were significantly positive, inferring that the laboratory
anti-Xa assay-dependent heparin measurement could be replaced with the HMS plus system [147].
iSTAT (Abbott Laboratories, Chicago, III, USA) is one of the most successful multi-test analysers,
offering a range of blood chemistry tests, cardiac markers and coagulation tests, including PT/INR and
ACT [148].
Helena Laboratories POC (Beaumont, Tex, USA) offers several POC devices, including the
Cascade POC analyser, Plateletworks® , and the Actalyke® family for monitoring antithrombotic
drugs, performing coagulation tests as well as platelet aggregation studies. The cascade POC analyser
can perform major coagulation tests such as ACT, PT, and aPTT. This system is comprised of test
cards with paramagnetic iron oxide particles and a unique combination of a photodetector and an
electromagnet to analyse the clotting time. Upon application of the blood sample to the reaction chamber
in the test card, it reacts with the reagent and paramagnetic particles. The electromagnet-induced
movement of paramagnetic particles will gradually decrease as the clot formation progresses, which is
detected optically. A photodetector collects the data of the light reflected based on the displacement
of paramagnetic particles, which are subsequently converted to the clotting time [149]. Actalyke
XL, the next generation ACT system, has two points clot detection technique, long measurement
range, and battery back-up. Alongside this, Helena Laboratories also provide a range of ACT assay
test tubes that are designed to be compatible with other devices such as the Hemochron series [21].
Instrumentation Laboratory’s (Bedford, MA, USA) multi-test device (GEM® PCL Plus) is a portable
whole blood coagulation analyser that provides rapid results for PT/INR, aPTT, and ACT.
Platelet function testing (PFT) can be utilized to study platelets by monitoring platelet dysfunction,
bleeding conditions, haemorrhagic disorders, perioperative haemostasis, and antiplatelet treatment.
Platelet aggregometry based on light transmission (LTA) is a gold standard method for PFT, but it is time
consuming and requires platelet-rich plasma samples. The POC devices such as Multiplate® analyser
(Multiple function platelet analyser, Roche Diagnostics, Basel, Switzerland) and PlateletWorks® (Helena
Laboratories, Beaumont, Tex, USA) use whole blood assays based on impedance aggregometry and
platelet reactivity [150]. The Multiplate® analyser consists of electrodes integrated with five test
channels that monitor the change (increase) in impedance observed as a consequence of platelet
aggregation. This multiple electrode aggregometry analyser proved to be a sensitive test for verifying
platelet dysfunction induced during extracorporeal circulation [151]. PlateletWorks® monitors platelet
activity by implementing Coulter counting to measure the platelet count pre and post aggregation.
The ratio of the platelet count in the control tube with ethylenediaminetetraacetic acid (EDTA) to the
aggregation activating citrated tube demonstrates the platelet adhesion and aggregation in a rapid
manner [149]. The PFA-100/200 (Siemens Corporation, Malvern, PA, USA) series platelet function
analyser has been on the market for more than 20 years and is used for the diagnosis of Von Willebrand
Disease (VWD) and other platelet disorders [152]. Shear stress-dependent platelet adhesion study can
be carried out by a cone and plate analyser where a rotating cone will generate uniform shear stress on
the sample over the plate. The IMPACT-R (Cone and Plate(Let) Analyzer (CPA), DiaMed, Cressier,
Switzerland) technology is beneficial in screening bleeding disorders and monitoring antiplatelet
therapy while utilizing only 130 µL of citrated whole blood [153]. A unique combination of optical
detection- and electromagnetic-induced mixing of samples and reagents is combined in the VerifyNow
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system (Accumetrics, San Diego, CA, USA). This device consists of an assay cartridge containing a
platelet agonist and fibrinogen beads (a platform for platelet adhesion) for monitoring antiplatelet
therapy. POC devices designed for examining the viscoelastic properties of whole blood include TEG®
(Haemonetics Corp., Braintree, MA, USA), ROTEM® (Pentapharm GmbH, Munich, Germany) and
Sonoclot Analyser (Sienco Inc., Boulder, CO, USA), which are widely used to obtain a detailed analysis
of clot formation and lysis in clinical setting [154–156].
The rise in oral antithrombotic therapy has intensified the development of innovative approaches
to monitoring the therapy. The ability to perform global haemostasis tests such as PT, aPTT, and ACT
in near-patient settings has improved clinical management. In the case of trauma, PFT and viscoelastic
POC devices have proved be significant aids in rapidly assessing the coagulation state [156,157].
With the introduction of next-generation technology, the accuracy and precision of POC devices is
continuously being improved and enhanced.
5. Conclusion and Future Perspective
Microfluidics is now established as a distinct technological field, although the development of
microfluidic devices only began circa 40 years ago. LOC technology has made it possible to carry out a
total analysis which includes sample preparation, chemical interactions, fluidic transport and detection
in one device within micrometer dimensions. These advantages have increased the application of
microfluidics in the biological diagnostics world. Along with this, the controlled environment of
micro-devices offers the ability to change the fluidic parameters, making it possible to study the
different stages of the thrombotic condition. For example, the changes in flow rate and pressure at
varied geometric dimensions mimicking the vascular haemodynamic circumstances have led to the
understanding of the role of various factors responsible for platelet aggregation during thrombosis.
The flexibility in developing the micro-channels of capillary sizes is also the result of advancements
in new materials and fabrication technologies. The possibility of introducing multi-channel reaction
chambers onto a single microchip is imperative in developing high throughput devices. This has also
contributed to fabricating devices that can conduct multiple parallel tests simultaneously, using the
sample in microlitre volumes. In addition to this, the method of patterning the desired protein onto a
material substrate has widened the research of haemostatically active proteins and their role in the
coagulation pathways. The adaptation of microelectronics fabrication methods in microfluidics has
made it possible to incorporate electrodes and sensors into the same device, further miniaturising the
device. Small diameters, accommodating low volumes of blood samples and reagents, have decreased
both the cost and the timing of experiments compared to conventional laboratory methods.
As the microfluidic field is multidisciplinary and still in its growing phase, there are certain
challenges faced by researchers. One of the limitations in developing biomimetic vascular models is
maintaining the constant shear rate throughout the micro-channel due to its rectangular geometric
design and fabrication [158]. This could be addressed by changes in design, such as creating circular
micro-channels instead of rectangular [159], which is expected to develop with the future advancements
in fabrication technologies. A multitude of assays are available for monitoring antithrombotic therapies
but incorporating the assay into a microfluidic device is a significant challenge. The major concerns
lie in the miniaturisation and transport of fluid within the micro-channels while maintaining the
sensitivity and specificity of the coagulation test.
The future expectation from microfluidic technology is the commercialisation of next generation
devices. Commercialisation in this space will depend upon factors such as ease of use, low cost and
reliability in terms of sensitivity and specificity. If these goals are achieved, there is a greater likelihood
of the growth of low-cost high-throughput devices which will provide rapid results in near-patient
settings in the field of haemostasis.
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